Hackensack UMC Multiple Sclerosis Center

Paramus, New Jersey

Academic MS Center
6 Active TrialsInfusion CenterLarge Center
11 MS centers statewide · Ranked #1 in New Jersey for clinical trials
What kind of place is this?
Comprehensive Care TeamResearch FocusedInfusion On-Site

You are looking at an academic MS center with a broad care team and many services in one place. You may appreciate the on-site infusion center, rehabilitation options, and access to specialists for vision, speech, thinking, and mood support. Because this is a large specialty center, visits may feel more structured than a small neighborhood practice.

Facility Profile
Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access2/5
Support Services5/5
Clinical Trials & Research5/5
Insurance & Navigation Help3/5
Scheduling & Virtual Care2/5

About Hackensack UMC Multiple Sclerosis Center

This center offers an on-site infusion center and a wide rehabilitation program. It also offers clinical trials and a multidisciplinary team that extends beyond neurology to include vision, urology, neuropsychology, and therapy services.

Hackensack UMC Multiple Sclerosis Center serves people with multiple sclerosis, neuromyelitis optica spectrum disorders, MOGAD, optic neuritis, transverse myelitis, and other related conditions. You can receive medical evaluations, imaging and lab work, infusion therapy, rehabilitation services, and support for vision, speech, swallowing, thinking, memory, and mood concerns. The center also offers an on-site infusion center and a clinical research program, along with mental health support groups. Its team includes neurologists, neuro-ophthalmologists, neuro-urologists, psychologists, rehabilitation therapists, and clinical neuropsychologists.

Hackensack UMC Multiple Sclerosis Center in Paramus is a comprehensive MS center that cares for people with multiple sclerosis and related nervous system conditions. You have access to a multidisciplinary team, on-site infusion services, and a broad mix of rehabilitation and specialty support in one setting. It is also part of Hackensack Meridian Health.

Featured Care Team Members

Krupa Shah Pandey, MD
Director of the MS Center and director of clinical trials
Neuroimmunology
Florian P. Thomas, MD, PhD
Founder of the MS Center; chair of the Department of Neurology and Neuroscience Institute
Neurology and neuroimmunology
Anuradha Singh, DO
Neuroimmunology
Judith Creighton, PHD
Clinical neuropsychology
Elizabeth A.C. Kera, PHD
Clinical neuropsychology
Olga M. Nikelshpur, PHD
Clinical neuropsychology
Jonathan Bryan Tiu, MD
Neurorehabilitation
Mohammed Shan Uddin, MD
Neuro-ophthalmology
Lana Zhovtis Ryerson, MD
Neuroimmunology
Maya Madhavan, MD
Neuroimmunology
Amos Katz, MD
Neuroimmunology
Patricia Mezzina, APN
Neurology

Specialized Programs

Full-spectrum rehabilitation
Cognitive and psychological support
Mental health mentorship program
Clinical research program
Infusion services
Vision therapy
Speech therapy
Swallow therapy

Partnerships & Referral Network

  • Hackensack Meridian John Theurer Cancer Center (collaboration for CAR T-cell study treatment oversight)

Services & Treatments

What They Treat
Multiple sclerosisRelapsing-remitting MSPrimary progressive MSSecondary progressive MSNeuromyelitis optica spectrum disordersNeuromyelitis opticaMOGADOptic neuritisTransverse myelitisAcute disseminated encephalomyelitisNeurosarcoidosisAutoimmune encephalitis
How They Treat It
Medical evaluationsOn-site infusion centerMobility screeningsVision servicesSpeech servicesThinking and memory appraisalsBotox injectionsBaclofen therapiesBladder, bowel and sexual function treatmentsNeuropsychological assessmentsPhysical therapyOccupational therapySpeech therapySwallow therapyPsychological supportPain managementHeadache managementInfusion therapyRehabilitation servicesClinical trialsLemtradaNovantroneOcrevusTysabriAvonexBetaseronCopaxoneAubagioGilenyaTecfideraBotox injectionsIntrathecal baclofen therapy pumpBaclofen pump managementInfusion therapyCAR T-cell therapyBruton’s Tyrosine Kinase inhibitorCognitive remediationPsychological counselingSpeech/language therapyModified barium swallowElectrical stimulation
Diagnostics
Blood workSpinal tapImaging studiesMRIMotor function assessmentNeuropsychological assessmentsMobility screeningsVision evaluationsThinking and memory appraisals

Research & Clinical Trials

This center is currently involved in 6 clinical trials — ranked #1 in New Jersey for active trials

A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
FenebrutinibOcrelizumabPlacebo matched to ocrelizumabPlacebo matched to fenebrutinib
A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
RECRUITINGPHASE1
CC-97540FludarabineCyclophosphamide
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
Amgen
RECRUITINGPHASE3
Ocrelizumab (US)Ocrelizumab (EU)ABP 692
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
Ofatumumab approved doseOfatumumab new dose
Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis
Hoffmann-La Roche
RECRUITING
MS Care Platform (icobrain ms and icompanion ms)
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
Johns Hopkins University
ACTIVE NOT RECRUITINGNA
Natalizumab/natalizumab-sztn, Alemtuzumab, Ocrelizumab, Rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, Cladribine, Ofatumumab, Ublituximab-xiiy, Ocrelizumab and hyaluronidase-ocsqGlatiramer acetate, Interferons (intramuscular, subcutaneous, pegylated) Teriflunomide, Fumarates (dimethyl, diroximel, monomethyl) Fingolimod, Siponimod, Ozanimod, Ponesimod

Insurance & Access

Contact
650 From Road #506, Paramus, NJ 07652
Insurance & Support
Care Coordinator
Support Groups

FAQs from Hackensack UMC Multiple Sclerosis Center

The center treats multiple sclerosis, including relapsing-remitting, primary progressive, and secondary progressive MS. It also cares for related conditions such as neuromyelitis optica spectrum disorders, MOGAD, optic neuritis, transverse myelitis, acute disseminated encephalomyelitis, neurosarcoidosis, and autoimmune encephalitis.

Yes. The center has an on-site infusion center and offers infusion therapy for patients who need it.

You can access services such as physical therapy, occupational therapy, speech therapy, swallow therapy, pain management, headache management, bladder and bowel care, and psychological support. The team also provides neuropsychological assessments, mobility screenings, and vision services.

Yes. Clinical trials are part of the center’s services, and the center has a clinical research program. The director of the MS Center also serves as the director of clinical trials.

Check out the MS Buddy App

Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.

Download on the App StoreGet it on Google Play
Call Website